Advisory Commission on Childhood Vaccines; Notice of Meeting, 6781 [E6-1733]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 27 / Thursday, February 9, 2006 / Notices
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES), written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Comments
received may be seen in the Division of
Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: February 1, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and
Radiological Health.
[FR Doc. E6–1787 Filed 2–8–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines; Notice of Meeting
cprice-sewell on PROD1PC66 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: March 9, 2006, 9 a.m.–3:30
p.m., EST.
Place: Audio Conference Call and
Parklawn Building, Conference Rooms G & H,
5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, March
9, from 9 a.m. to 3:30 p.m. The public can
join the meeting in person at the address
listed above or by audio conference call by
dialing 1–800–369–6048 on March 9 and
providing the following information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the March
meeting will include, but are not limited to:
An overview of compensation programs in
other countries; results of the National
Vaccine Injury Compensation Program’s
(VICP) Program Assessment Rating Tool; a
discussion of the Division of Vaccine Injury
Compensation’s (DVIC) communication
strategies; a report from the ACCV
Workgroup looking at proposed guidelines
for future changes to the Vaccine Injury
Table; and updates from DVIC, Department of
Justice, National Vaccine Program Office,
Immunization Safety Office (Centers for
Disease Control and Prevention), National
Institute of Allergy and Infectious Diseases
VerDate Aug<31>2005
16:34 Feb 08, 2006
Jkt 208001
(National Institutes of Health), and Center for
Biologics and Evaluation Research (Food and
Drug Administration). Agenda items are
subject to change as priorities dictate.
Public Comments: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C–26, 5600
Fishers Lane, Rockville, Maryland 20857 or
e-mail clee@hrsa.gov. Requests should
contain the name, address, telephone
number, and any business or professional
affiliation of the person desiring to make an
oral presentation. Groups having similar
interests are requested to combine their
comments and present them through a single
representative. The allocation of time may be
adjusted to accommodate the level of
expressed interest. DVIC will notify each
presenter by mail or telephone of their
assigned presentation time. Persons who do
not file an advance request for a presentation,
but desire to make an oral statement, may
announce it at the time of the comment
period. These persons will be allocated time
as it permits.
For Further Information Contact: Anyone
requiring information regarding the ACCV
should contact Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, HSB, HRSA, Room 11C–
26, 5600 Fishers Lane, Rockville, MD 20857;
telephone (301) 443–2124 or e-mail
clee@hrsa.gov.
Dated: February 2, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–1733 Filed 2–8–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Privacy Act System of Records Notice
09–17–0001, ‘‘Medical, Health and
Billing Records’’: Correction
AGENCY:
Indian Health Service (IHS),
HHS.
ACTION:
Notice: correction.
SUMMARY: The Indian Health Service
published a document in the Federal
Register on December 30, 2005. The
document contained an error.
FOR FURTHER INFORMATION CONTACT:
Contact Ms. Patricia Gowan, IHS Lead
Health Information Management (HIM)
Consultant (Acting), Office of Health
Programs, Phoenix Area Office IHS,
Two Renaissance Square, Suite 606, 40
North Central Avenue, Phoenix, AZ
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
6781
85004 or via the Internet at
Patricia.Gowan@ihs.gov.
Correction
In the Federal Register of December
30, 2005, in FR Doc 05–24644, on page
77407, in the second column, correct
number 5 to read: ‘‘Records may be
disclosed to the Bureau of Indian Affairs
(BIA) or its contractors under an
agreement between IHS and the BIA
relating to disabled AI/AN children for
the purposes of carrying out its
functions under the Individuals with
Disabilities Education Act (IDEAS), 20
U.S.C. 1400, et seq.’’
Re-number 5 to number 6 and so forth
for a total of twenty-four routine uses
instead of twenty-three.
Dated: February 2, 2006.
Robert G. McSwain,
Deputy Director, Indian Health Service.
[FR Doc. 06–1188 Filed 2–8–06; 8:45 am]
BILLING CODE 4165–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Inspector General
Program Exclusions: January 2006
AGENCY:
Office of Inspector General,
HHS.
ACTION:
Notice of program exclusions.
During the month of January 2006, the
HHS Office of Inspector General
imposed exclusions in the cases set
forth below. When an exclusion is
imposed, no program payment is made
to anyone for any items or services
(other than an emergency item or
service not provided in a hospital
emergency room) furnished, ordered or
prescribed by an excluded party under
the Medicare, Medicaid, and all Federal
Health Care programs. In addition, no
program payment is made to any
business or facility, e.g., a hospital, that
submits bills for payment for items or
services provided by an excluded party.
Program beneficiaries remain free to
decide for themselves whether they will
continue to use the services of an
excluded party even though no program
payments will be made for items and
services provided by that excluded
party. The exclusions have national
effect and also apply to all Executive
Branch procurement and nonprocurement programs and activities.
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 71, Number 27 (Thursday, February 9, 2006)]
[Notices]
[Page 6781]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1733]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date and Time: March 9, 2006, 9 a.m.-3:30 p.m., EST.
Place: Audio Conference Call and Parklawn Building, Conference
Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, March 9, from 9 a.m. to 3:30
p.m. The public can join the meeting in person at the address listed
above or by audio conference call by dialing 1-800-369-6048 on March
9 and providing the following information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the March meeting will include, but
are not limited to: An overview of compensation programs in other
countries; results of the National Vaccine Injury Compensation
Program's (VICP) Program Assessment Rating Tool; a discussion of the
Division of Vaccine Injury Compensation's (DVIC) communication
strategies; a report from the ACCV Workgroup looking at proposed
guidelines for future changes to the Vaccine Injury Table; and
updates from DVIC, Department of Justice, National Vaccine Program
Office, Immunization Safety Office (Centers for Disease Control and
Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health), and Center for Biologics and
Evaluation Research (Food and Drug Administration). Agenda items are
subject to change as priorities dictate.
Public Comments: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Ms. Cheryl Lee, Principal Staff Liaison,
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville,
Maryland 20857 or e-mail clee@hrsa.gov. Requests should contain the
name, address, telephone number, and any business or professional
affiliation of the person desiring to make an oral presentation.
Groups having similar interests are requested to combine their
comments and present them through a single representative. The
allocation of time may be adjusted to accommodate the level of
expressed interest. DVIC will notify each presenter by mail or
telephone of their assigned presentation time. Persons who do not
file an advance request for a presentation, but desire to make an
oral statement, may announce it at the time of the comment period.
These persons will be allocated time as it permits.
For Further Information Contact: Anyone requiring information
regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff
Liaison, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville,
MD 20857; telephone (301) 443-2124 or e-mail clee@hrsa.gov.
Dated: February 2, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-1733 Filed 2-8-06; 8:45 am]
BILLING CODE 4165-15-P
